Abstract

Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome)

Author(s): Riepl Mike

Issue: May/Jun 2019 - Volume 23, Number 3

Page(s): 192-199

Download in electronic PDF format for $75
  • Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 1
  • Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 2
  • Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 3
  • Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 4
  • Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 5
  • Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 6
  • Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 7
  • Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Page 8

Abstract

Polycystic ovary syndrome (Stein- Leventhal syndrome) is a common endocrinopathologic condition in reproductive- age women in the U.S. Patients with that disease are not faced with treatment choices for a single medical entity; they must manage a constellation of comorbid conditions that compromise their overall health and diminish their quality of life. The combinations of those disorders are unique to each patient. As a result, the safest and most effective therapeutic approach often requires precision pharmacy: the use of compounded therapies that, unlike commercially manufactured medications, can be precisely adjusted to meet individual needs and modified as therapeutic requirements change. In this article, the manifestations of polycystic ovary syndrome are reviewed, several common concomitant conditions are discussed, therapeutic interventions are suggested, and compounded formulations are provided.

Related Keywords

  • polycystic ovary syndrome
  • chronic anovulation
  • hyperandrogenism
  • polycystic ovaries
  • obesity
  • menstrual dysfunction
  • insulin resistance
  • metformin
  • infertility
  • hypothalamic-pituitary-adrenal axis
  • HPA axis
  • emotional stress
  • sex hormones
  • formulations
  • calcium supplementation
  • magnesium supplementation
  • vitamin D3 supplementation
  • zinc supplementation
  • hyperinsulinemia
  • cortisol
  • dietary recommendations

Related Categories

  • FORMULATIONS
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2019
Pg. 192-199
Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome)
Author(s): Riepl Mike
Jan/Feb 2003
Pg. 27-29
Equine Cushing’s Syndrome
Author(s): Vail Jane
Jul/Aug 2015
Pg. 289-293
Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity
Author(s): Biundo Bruce, Gogola Margaret
May/Jun 2016
Pg. 197-201
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients
Author(s): Sturn Kayla M, Collin Michael
Mar/Apr 2018
Pg. 172-175
Topical Ketamine in the Treatment of Complex Regional Pain Syndrome
Author(s): Durham Melissa J, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H
May/Jun 2007
Pg. 187-192
Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited
Author(s): Vail Jane
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Jul/Aug 2005
Pg. 259-264
View Sample
Testosterone Replacement Therapy for Female Androgen Insufficiency Syndrome
Author(s): Tan Robert S
Jan/Feb 2010
Pg. 40-45
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis
Author(s): Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R
Sep/Oct 2022
Pg. 378-384
Compounded Medications and Probiotics for Irritable Bowel Syndrome
Author(s): Narváez Katherine Rivera, Thompson Tara
Sep/Oct 2020
Pg. 367-369
Topical Cholesterol/Simvastatin Gel for the Treatment of CHILD Syndrome in an Adolescent
Author(s): Cho Sung Kyung, Ashworth Lisa Diggs, Goldman Shauna
May/Jun 2012
Pg. 196-205
Burning Mouth Syndrome: A Discussion of a Complex Pathology
Author(s): Zur Eyal
Nov/Dec 2013
Pg. 446-450
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2
Author(s): Horace Alexis E, Akbarian-Tefagh Jessica
Sep/Oct 2014
Pg. 370-377
Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report
Author(s): Mixon Bill, Mixon Jan, Isbey Edward K III, Sprinkle Shari
Mar/Apr 2001
Pg. 136-139
Infertility Care and the Role of the Compounding Pharmacist
Author(s): Filicpzuk Janina
Sep/Oct 1999
Pg. 344-348
Wilson's Syndrome and T3 Therapy
Author(s): Milner Martin
Sep/Oct 1999
Pg. 366-367
Feline Urologic Syndrome and Diet Formulation
Author(s): Long Scott F
Sep/Oct 2000
Pg. 334
Human Immunodeficiency Virus and the Acquired Immune Deficiency Syndrome
Author(s): Mathews Elizabeth
Sep/Oct 2000
Pg. 338
Clinical Management and Review of Sjogren's Syndrome
Author(s): Dyke Shannon
Sep/Oct 2000
Pg. 349
Probiotics and Their Effect on Leaky Gut Syndrome and Associated Diseases
Author(s): Hinze John, Mahan Tracy